Clinical Trials Browser

Has results × Glioblastoma × Ipilimumab × Clear all

NCT03430791 2023-02-02

Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma

Phase 2 Terminated

5 enrolled 10 charts

Glioblastoma